However, a recent association study of KRAS genotype and clinicopathological findings of early-resected NSCLC tumors suggested that the G12V genotype was closely associated with enhanced fatty acid and amino acid metabolism.48 Although not explicitly stated in this study, both pathways are consistent with elevated mTORC1 activity. Here, KRAS is linked to non-small cell lung carcinoma.